Lpr-induced systemic autoimmunity is unaffected by mast cell deficiency

Area of Science:

• Immunology
• Autoimmunity
• Cell Biology

Background:

• Mast cells are implicated in allergic and autoimmune responses, but their precise role in systemic autoimmunity remains debated.
• The B6(lpr/lpr) mouse model spontaneously develops systemic lupus erythematosus (SLE), offering a platform to study autoimmune pathogenesis.

Purpose of the Study:

• To investigate the function of mast cells in systemic autoimmunity using the B6(lpr/lpr) mouse model of SLE.
• To determine if mast cell deficiency influences the development and severity of lupus in this model.

Main Methods:

• B6(lpr/lpr) mice were crossed with C57Bl/6-Kit(W-sh/W-sh) (Wsh) mice to generate mast cell-deficient offspring (Lpr/Wsh).
• Evaluated lupus severity by assessing autoantibody production, proteinuria, immune cell populations, and autoimmune pathology in Lpr/Wsh and B6(lpr/lpr) mice.

Main Results:

• Mast cell deficiency did not affect autoantibody levels, proteinuria, T and B cell composition, or overall autoimmune pathology in lupus-prone mice.
• Reduced c-Kit expression, associated with mast cell deficiency, led to splenomegaly and impaired interleukin-4 production by CD4(+) T cells, suggesting minor mast cell functions.

Conclusions:

• Mast cell deficiency does not play a significant role in the pathogenesis of lupus in the B6(lpr/lpr) mouse model.
• While mast cells have minor functions, their absence does not alter the core autoimmune disease progression in this SLE model.